Medical News

RSS

National Black HIV/AIDS Day brings new statistics

According to statistics from the Centers for Disease Control (CDC), Blacks represent approximately 14 percent of the U.S. population, but accounted for an estimated 44 percent of new HIV infections in 2009. Over the same period, the rate of new HIV infections among black women was 15 times that of White women, and over 3 times the rate of Hispanic/Latina women.

7 Feb 2012

Bread to blame for too much salt in American diet: CDC report

According to the latest figures released by the Centers for Disease Control and Prevention (CDC) this Tuesday, nine out of 10 American adults consume too much salt.

7 Feb 2012

High soft drink consumption associated with asthma and COPD

A new study published in the journal Respirology reveals that a high level of soft drink consumption is associated with asthma and/or chronic obstructive pulmonary disease (COPD).

7 Feb 2012

WHO publishes new standards for human participant research

The World Health Organization (WHO) has published “Standards and Operational Guidance for Ethics Review of Health-Related Research with Human Participants,” a compilation of 10 standards for ethics review of health related research with human participants.

7 Feb 2012

NHS spends a whopping on £60,000 a day on translation services: Report

A new report shows that Britain’s NHS pays out £60,000 a day on translation and interpretation services, with Leeds among the highest spenders. Research by think-tank 2020Health showed NHS trusts spent £23.3 million on written translation and interpreters last year, an increase of 17% since 2007.

7 Feb 2012

Facebook and Twitter addiction: Study

The researchers from the University of Chicago’s Booth School of Business recently conducted an experiment involving 205 people in Wurtzburg, Germany to analyze the addictive properties of social media and other vices.

7 Feb 2012

Merck applies for approval of its new insomnia drug suvorexant

Merck & Co. announced this Monday that they would file for U.S. marketing approval of their experimental insomnia drug suvorexant in 2012.

7 Feb 2012

Asthmatic mothers encouraged to breastfeed without fear as it boosts baby’s lung power: Study

In their study published in the American Journal of Respiratory and Critical Care Medicine they looked at nearly 1,500 children from birth to ages eight to 14. Parents provided information on breastfeeding history when their children were 12 months old, and the children had a series of tests to assess lung function between the ages of 8 and 14.

7 Feb 2012

FDA reviews Amgen’s prostate cancer drug Xgeva

U.S. Food and Drug Administration (FDA) researchers say that an Amgen drug slowed the spread of cancer to the bone in men with hard-to-treat prostate cancer, though the drug did not extend life and carried significant side effects.

7 Feb 2012

World’s first 3D printed jaw transplant

In a medical breakthrough, doctors and bio-engineers have collaborated

7 Feb 2012

Proposed Australian e-health records system criticised

Both the Medical Software Industry Association (MSIA) and the Australian Privacy Foundation have criticized the private corporation established by the federal and state governments to roll out the federal government's proposed electronic health records. They have told a Senate inquiry hearing in Canberra that personally-controlled e-health records should not go live on July 1 as planned.

7 Feb 2012

Spectros 2011 sales revenue increases 69%

Spectros announced today that year-over-year sales revenue rose 69% in 2011. This is the fourth year in a row for double-digit revenue growth for Spectros since the current T-Stat Oximeter was launched in 2008.

7 Feb 2012

Clinical Cancer Research publishes results of Aduro's ANZ-100 and CRS-207 Phase 1 studies

Aduro BioTech, Inc. is pleased to announce the publication of two therapeutic cancer vaccine Phase 1 studies in Clinical Cancer Research. In the article, which was featured as one of the highlights of the issue, Dr. Dung Le et al. reported that intravenous administration of ANZ-100 and CRS-207 was well tolerated in subjects with advanced, treatment-refractory cancers.

7 Feb 2012

Ultrasound makes arthritis evaluation and treatment quicker and more accurate

Ultrasound is transforming the way arthritis is diagnosed and treated, making evaluation and treatment quicker and more accurate. The new approach is dubbed fast arthritis sonographic evaluation and treatment, or FAST, by rheumatologists at NewYork-Presbyterian Hospital/Columbia University Medical Center who are leading its development.

7 Feb 2012

Antiretroviral therapy does not increase severity of psychiatric disorders

A study of more than 300 children and adolescents with human immunodeficiency virus (HIV) revealed no association between specific antiretroviral therapy and the severity of psychiatric disorders.

7 Feb 2012

NYU Langone experts to present at American Academy of Orthopaedic Surgeons annual meeting

Experts from the Department of Orthopaedic Surgery at NYU Langone Medical Center will present their latest research and clinical findings on diseases of the muscle, tendon, bone and joint at the annual meeting of the American Academy of Orthopaedic Surgeons (AAOS), February 7-11 in San Francisco, California.

7 Feb 2012

ECNP expresses deep concern at withdrawal by AstraZeneca from neuroscience drug research

The European College of Neuropsychopharmacology expresses its deep concern at the recently announced withdrawal by AstraZeneca from neuroscience drug research. AstraZeneca's pull-out is especially disturbing given that it follows a series of similar withdrawals in the last two years by major pharmaceutical companies. There is a growing sense that neuroscience in Europe is now facing a severe crisis.

7 Feb 2012

BD first quarter revenues increase 2.5% to $1.888 billion

BD, a leading global medical technology company, today reported quarterly revenues of $1.888 billion for the first fiscal quarter ended December 31, 2011, representing an increase of 2.5 percent from the prior-year period, or 2.4 percent on a foreign currency-neutral basis.

From BD (Becton, Dickinson and Company) 7 Feb 2012

Three new targeted drugs can lead to fatal cancer complications

Treatment with three relatively new "targeted" cancer drugs has been linked to a slightly elevated chance of fatal side effects, according to a new analysis led by scientists at Dana-Farber Cancer Institute. They added that the risk remains low, but should be taken into account by physicians and patients.

7 Feb 2012

ED can lead to potential cardiovascular disease in men

More than 12 million men have type 2 diabetes and that number is growing at an alarming rate. A little talked about complication of this disease is erectile dysfunction (ED), which can lead to an even more serious condition.

7 Feb 2012